Safety And Efficacy Study Of The Combination Of CpG 7909 And Herceptin In Patients With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Carcinoma, Metastatic Breast
Interventions: DRUG: CPG 7909|DRUG: Herceptin®|DRUG: CPG 7909|DRUG: Herceptin®|DRUG: CPG 7909|DRUG: Herceptin®|DRUG: CPG 7909|DRUG: Herceptin®
Sponsor: Pfizer